Neogen Corp (NEOG) Beats Expectations Amid Leadership Change and Restructuring Efforts

We recently published 12 Best Healthcare Stocks to Buy Under $30. Neogen Corporation (NASDAQ:NEOG) is one of the best healthcare stocks.

Neogen Corporation, specializing in food and animal safety diagnostics, is currently undergoing a strategic transition amid operational challenges. As of August 2025, the company faced integration issues from past mergers and reported weaker Q3 2025 earnings, leading to lowered full-year guidance and an announced CEO departure later this year.

Despite these setbacks, Neogen Corporation is divesting non-core operations to reduce debt and improve future growth prospects. Investors like Baron Funds view this restructuring as a temporary phase before a stronger rebound. The business operates mainly in Food Safety and Animal Safety, providing diagnostic kits for contaminants and veterinary products, reinforcing its role in global food and animal health.

A notable recent development is Neogen Corporation’s August 2025 collaboration with enzyme design firm Biomatter, signaling a strategic move toward biotechnological innovation. Additionally, the company’s Q2 CY2025 results beat revenue expectations despite a 4.8% year-over-year sales decline, demonstrating some resilience in a difficult market environment.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.